The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70.
Here’s the latest list of major overbought players in this sector.
Femasys Inc. (NASDAQ: FEMY)
- The company received FDA 510(k) clearance for FemaSeed, an infertility treatment, towards the end of September. The company’s stock has a 52-week high of $4.75. .
- RSI Value: 72.93
- FEMY Price Action: Shares of Femasys fell 36% to close at $2.49 on Tuesday.